Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Summary

This study aims to investigate the effects of a single dose of the glucagon-like 1 receptor agonist semaglutdie/Rybelsus on the hypothalamo-pituitary-adrenal axis, thus cortisol levels and other stresshormones in healthy males.

Timeline

Start

2025-01-16

Primary completion

2025-10-31

Completion

2025-11-30

Drugs

Indications